Insider · CIK 0001799780

Quigley Jill M.

Reports to the SEC for 3 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001799780

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.7K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,955 sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,697 sh	—	—	0
2026-02-01	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,697 sh	—	—	1,697
2025-11-04	TERNTerns Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+24.5K sh	$9.24	+$227K	24,520
2025-11-04	TERNTerns Pharmaceuticals, Inc.S Sale	Director	SSale	−24.5K sh	$18.00	−$441K	0
2025-11-04	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−24.5K sh	—	—	3,955
2025-06-11	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-02-01	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.7K sh	—	—	10,657
2025-01-06	TERNTerns Pharmaceuticals, Inc.S Sale	Director	SSale	−8,760 sh	$5.79	−$50.8K	0
2025-01-02	TERNTerns Pharmaceuticals, Inc.S Sale	Director	SSale	−6,240 sh	$5.72	−$35.7K	8,760
2024-09-09	TERNTerns Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.2K sh	$1.82	+$31.4K	32,235
2024-09-09	TERNTerns Pharmaceuticals, Inc.S Sale	Director	SSale	−17.2K sh	$10.00	−$172K	15,000
2024-09-09	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.2K sh	—	—	0
2024-08-02	TERNTerns Pharmaceuticals, Inc.S Sale	Director	SSale	−8,857 sh	$7.50	−$66.4K	15,000
2024-08-01	TERNTerns Pharmaceuticals, Inc.S Sale	Director	SSale	−6,143 sh	$7.68	−$47.1K	23,857
2024-07-16	TERNTerns Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+400 sh	$1.82	+$728	30,400
2024-07-16	TERNTerns Pharmaceuticals, Inc.S Sale	Director	SSale	−400 sh	$10.00	−$4,000	30,000
2024-07-16	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−400 sh	—	—	17,235
2024-07-15	TERNTerns Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14.4K sh	$1.82	+$26.1K	44,365
2024-07-15	TERNTerns Pharmaceuticals, Inc.S Sale	Director	SSale	−14.4K sh	$10.00	−$144K	30,000
2024-07-15	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−14.4K sh	—	—	17,635
2024-06-10	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2024-01-23	TERNTerns Pharmaceuticals, Inc.A Award	Director	AAward	+15K sh	—	—	30,000
2023-11-15	TERNTerns Pharmaceuticals, Inc.A Award	Director	AAward	+15K sh	—	—	15,000
2023-06-16	CMMBChemomab Therapeutics Ltd. · Option to Purchase American Depositary SharesA Award	Director	AAward	+6,857 sh	—	—	20,497
2023-06-12	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2022-06-16	CMMBChemomab Therapeutics Ltd. · Option to Purchase American Depositary SharesA Award	Director	AAward	+13.6K sh	—	—	13,640
2022-06-16	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2021-12-08	PASGPassage BIO, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+72K sh	$0.23	+$16.6K	368,754
2021-12-08	PASGPassage BIO, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−11.2K sh	—	—	3,729
2021-12-08	PASGPassage BIO, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−60.8K sh	—	—	27,626
2021-09-28	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2021-02-16	PASGPassage BIO, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+105K sh	—	—	105,000
2021-01-20	PASGPassage BIO, Inc.S Sale	Chief Operating Officer	SSale	−1,300 sh	$30.01	−$39K	295,284
2021-01-14	PASGPassage BIO, Inc.S Sale	Chief Operating Officer	SSale	+16.3K sh	$30.10	+$491K	296,584
2020-03-03	PASGPassage BIO, Inc.P Purchase	Chief Operating Officer	PPurchase	+1,500 sh	$18.00	+$27K	311,494
2020-03-03	PASGPassage BIO, Inc.P Purchase	Chief Operating Officer	PPurchase	+1,000 sh	$18.00	+$18K	1,000
2020-02-27	PASGPassage BIO, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+211K sh	—	—	211,001

Recent filings

Accepted (ET)
May 54
Quigley Jill M.0001799780-26-000004
SEC(opens sec.gov)
Feb 24
Quigley Jill M.0001799780-26-000002
SEC(opens sec.gov)
Nov 54
Quigley Jill M.0001799780-25-000004
SEC(opens sec.gov)
Jun 124
Quigley Jill M.0001562180-25-004756
SEC(opens sec.gov)
Feb 34
Quigley Jill M.0001562180-25-000856
SEC(opens sec.gov)
Jan 64
Quigley Jill M.0001562180-25-000219
SEC(opens sec.gov)
Sep 114
Quigley Jill M.0001562180-24-006776
SEC(opens sec.gov)
Aug 54
Quigley Jill M.0001562180-24-006019
SEC(opens sec.gov)

Companies

Address

C/O TERNS PHARMACEUTICALS, INC. 1065 EAST HILLSDALE BLVD., SUITE 100

FOSTER CITY, CA, 94404